Medline Inc. (MDLN): Capital Expenditures

Annual figures by period end, from SEC filings.

$447.00M

Year ended 2025-12-31

$446.00M

Trailing 12 months to 2026-06-27

2023-12-31 Capital Expenditures (USD) 2025-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2025-12-31	$447.00M	+26.3%	2026-02-25, From 2025-01-01
2024-12-31	$354.00M	+28.7%	2026-02-25, From 2024-01-01
2023-12-31	$275.00M	n/a	2026-02-25, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Capital Expenditures	Change YoY
Medline Inc. (MDLN)	2025-12-31	$447.00M	+26.3%
Stryker Corp (SYK)	2025-12-31	$761.00M	+0.8%
3M Co (MMM)	2025-12-31	$910.00M	-22.9%
Becton Dickinson & Co (BDX)	2025-09-30	$760.00M	+4.8%
Boston Scientific Corp (BSX)	2025-12-31	$876.00M	+10.9%
Baxter International Inc (BAX)	2025-12-31	$513.00M	+15.0%
Solventum Corp (SOLV)	2025-12-31	$379.00M	-0.3%
ResMed Inc (RMD)	2026-06-30	$156.28M	+73.9%
Dexcom Inc (DXCM)	2025-12-31	$363.50M	+1.3%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗